Ariad Pharma Under Fire for Leukemia Drug Pricing

Oct 20, 2016

Reuters

Former Democratic presidential candidate Bernie Sanders and U.S. Representative Elijah Cummings sent a letter to Ariad Pharmaceuticals questioning the "staggering" price increases for the company's leukemia drug, according to a Reuters article.

Sanders recently tweeted that: "Drug corporations' greed is unbelievable. Ariad raised the price of a leukemia drug to almost $199,000 a year."

The drug, Iclusig, is used to treat chronic myeloid leukemia, a type of bone marrow cancer in which marrow makes too many white blood cells.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments